Synthesis shows successful formation of (−)‐verrucarol using asymmetric synthesis and chiral Lewis acid-catalyzed processes, indicating new pathways for trichothecene compounds.
We disclose a concise, asymmetric synthesis of (−)‐verrucarol, the natural product precursor of bioactive trichothecene macrocycles including verrucarins A and J. Historically, enantioselective construction of the 6/6/5 (A/B/C) ring system of the 12,13‐epoxytrichothec‐9‐ene (EPT) core of trichothecene natural products has been a significant challenge. This architecture was constructed beginning with a chiral Lewis acid‐catalyzed, enantioselective [4+2] cycloaddition to afford a cis ‐fused A/B ring fragment. A mechanistic hypothesis for the pivotal [4+2] cycloaddition was developed through experimentation and density functional theory (DFT). En route to completing the 6/6/5 core, we demonstrate diastereoselective modifications of the [4+2] cycloadduct including silylative generation and addition to a vinyl oxocarbenium. Final C‐ring closure was achieved by a diastereoselective 5‐endo‐trig cyclization, thereby completing formal [3+2] annulation over two steps. Late‐stage alkene transposition and hydroxyl‐directed epoxidation furnished the target compound, (−)‐verrucarol.
No takes yet. Share an insight, caveat, or question.
Powers et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: